Some analysts are more optimistic about CVS’ ability to navigate higher-than-expected medical costs in its insurance unit ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...
CVS Health’s adjusted fourth-quarter profit handily beat Wall Street’s estimates, even as the drugstore chain and pharmacy benefits manager dealt with rising costs in its insurance division ...
Truist analyst David MacDonald raised the firm’s price target on CVS Health (CVS) to $76 from $60 and keeps a Buy rating on the shares after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results